SINGAPORE – Ms W was diagnosed with third-stage ovarian cancer in October 2020 and is being treated at the National University Cancer Institute as a subsidised patient.
Her treatment cost was fully covered by national insurance scheme MediShield Life and national medical savings scheme MediSave, until December 2022, when she had to top up $268.50 in cash. This came as a shock.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
